Nintedanib in progressive fibrosing interstitial lung diseases KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ... New England Journal of Medicine 381 (18), 1718-1727, 2019 | 1769 | 2019 |
Nintedanib for systemic sclerosis–associated interstitial lung disease O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ... New England Journal of Medicine 380 (26), 2518-2528, 2019 | 1354 | 2019 |
Withdrawal of inhaled glucocorticoids and exacerbations of COPD H Magnussen, B Disse, R Rodriguez-Roisin, A Kirsten, H Watz, K Tetzlaff, ... New England Journal of Medicine 371 (14), 1285-1294, 2014 | 795 | 2014 |
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial H Watz, K Tetzlaff, EFM Wouters, A Kirsten, H Magnussen, ... The lancet Respiratory medicine 4 (5), 390-398, 2016 | 507 | 2016 |
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4) R Buhl, F Maltais, R Abrahams, L Bjermer, E Derom, G Ferguson, ... European Respiratory Journal 45 (4), 969-979, 2015 | 439 | 2015 |
The natural history of progressive fibrosing interstitial lung diseases KK Brown, FJ Martinez, SLF Walsh, VJ Thannickal, A Prasse, ... European Respiratory Journal 55 (6), 2020 | 204 | 2020 |
Trial of spesolimab for generalized pustular psoriasis H Bachelez, SE Choon, S Marrakchi, AD Burden, TF Tsai, A Morita, ... New England Journal of Medicine 385 (26), 2431-2440, 2021 | 203 | 2021 |
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease KM Beeh, J Westerman, AM Kirsten, J Hébert, L Grönke, A Hamilton, ... Pulmonary pharmacology & therapeutics 32, 53-59, 2015 | 156 | 2015 |
Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity M Reuter, A Schnabel, F Wesner, K Tetzlaff, Y Risheng, WL Gross, ... Chest 114 (2), 500-506, 1998 | 142 | 1998 |
Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease PMA Calverley, K Tetzlaff, C Vogelmeier, LM Fabbri, H Magnussen, ... American journal of respiratory and critical care medicine 196 (9), 1219-1221, 2017 | 141 | 2017 |
Risk factors for pulmonary barotrauma in divers K Tetzloff, E Bettinghausen, M Renter, M Heller, B Leplow Chest 112 (3), 654-659, 1997 | 140 | 1997 |
Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD DM Mannino, R Tal-Singer, DA Lomas, J Vestbo, G Barr, K Tetzlaff, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2 (1), 23, 2015 | 125 | 2015 |
The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortium B Celli, K Tetzlaff, G Criner, MI Polkey, F Sciurba, R Casaburi, ... American journal of respiratory and critical care medicine 194 (12), 1483-1493, 2016 | 124 | 2016 |
MR imaging of the central nervous system in diving-related decompression illness M Reuter, K Tetzlaff, A Hutzelmann, G Fritsch, JC Steffens, ... Acta Radiologica 38 (6), 940-944, 1997 | 98 | 1997 |
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease PG Woodruff, M Wolff, JM Hohlfeld, N Krug, MT Dransfield, ER Sutherland, ... American journal of respiratory and critical care medicine 181 (5), 438-445, 2010 | 95 | 2010 |
Development and validation of a cough and sputum assessment questionnaire B Crawford, B Monz, J Hohlfeld, N Roche, B Rubin, H Magnussen, ... Respiratory medicine 102 (11), 1545-1555, 2008 | 88 | 2008 |
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment IP Hall, AV Fowler, A Gupta, K Tetzlaff, MC Nivens, M Sarno, HA Finnigan, ... Pulmonary pharmacology & therapeutics 32, 37-44, 2015 | 84 | 2015 |
Arteriovenous bubbles following cold water sport dives: relation to right-to-left shunting T Gerriets, K Tetzlaff, T Liceni, C Schafer, B Rosengarten, G Kopiske, ... Neurology 55 (11), 1741-1743, 2000 | 77 | 2000 |
Breathing at depth: physiologic and clinical aspects of diving while breathing compressed gas K Tetzlaff, E Thorsen Clinics in chest medicine 26 (3), 355-380, 2005 | 68 | 2005 |
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis … SE Choon, MG Lebwohl, S Marrakchi, AD Burden, TF Tsai, A Morita, ... BMJ open 11 (3), e043666, 2021 | 66 | 2021 |